Armata Pharmaceuticals, Inc.
ARMP
$1.42
$0.06815.04%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.92M | -41.36M | -67.04M | -79.58M | -69.05M |
| Total Depreciation and Amortization | 1.33M | 1.24M | 1.15M | 1.06M | 972.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.86M | 5.13M | 29.05M | 42.09M | 30.30M |
| Change in Net Operating Assets | -2.10M | -2.73M | -1.70M | -4.01M | -9.65M |
| Cash from Operations | -37.55M | -37.73M | -38.55M | -40.44M | -47.42M |
| Capital Expenditure | -1.88M | -4.36M | -7.53M | -6.38M | -8.14M |
| Sale of Property, Plant, and Equipment | -- | 10.00K | 10.00K | 10.00K | 10.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.88M | -4.35M | -7.52M | -6.37M | -8.13M |
| Total Debt Issued | 34.89M | 34.89M | 59.69M | 59.32M | 54.03M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 130.00K | 130.00K | 135.00K | 47.00K | 5.00K |
| Repurchase of Common Stock | -61.00K | -104.00K | -43.00K | -43.00K | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 34.96M | 34.92M | 59.78M | 59.33M | 53.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.47M | -7.16M | 13.71M | 12.51M | -1.57M |